Scarica l'app Stockscreener
5.62
4.42%
-0.26
Precedente Chiudi:
$5.88
Aprire:
$5.88
Volume 24 ore:
79,897
Relative Volume:
0.76
Capitalizzazione di mercato:
$66.24M
Reddito:
$52.29M
Utile/perdita netta:
$-73.52M
Rapporto P/E:
-8.5152
EPS:
-0.66
Flusso di cassa netto:
$-100.45M
1 W Prestazione:
+3.31%
1M Prestazione:
+12.18%
6M Prestazione:
+32.86%
1 anno Prestazione:
-37.28%
Intervallo 1D:
$5.54
$5.9399
Intervallo di 1 settimana:
$5.3964
$5.9399
Portata 52W:
$3.61
$9.2464
Precision Biosciences Inc Stock (DTIL) Company Profile
Nome
Precision Biosciences Inc
Settore
Industria
Telefono
919-314-5512
Indirizzo
302 EAST PETTIGREW STREET, DURHAM, NC
Confronta DTIL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DTIL
Precision Biosciences Inc
|
5.62 | 69.31M | 52.29M | -73.52M | -100.45M | -0.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-10 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2024-04-30 | Iniziato | Guggenheim | Buy |
| 2022-06-17 | Iniziato | BMO Capital Markets | Outperform |
| 2022-06-09 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2020-07-27 | Ripresa | BTIG Research | Buy |
| 2020-04-03 | Downgrade | Goldman | Buy → Neutral |
| 2020-03-05 | Iniziato | Stifel | Buy |
| 2020-02-25 | Iniziato | William Blair | Outperform |
| 2019-08-09 | Iniziato | BTIG Research | Buy |
| 2019-07-16 | Iniziato | H.C. Wainwright | Buy |
| 2019-04-22 | Iniziato | Barclays | Overweight |
| 2019-04-22 | Iniziato | Goldman | Buy |
| 2019-04-22 | Iniziato | JP Morgan | Overweight |
| 2019-04-22 | Iniziato | Jefferies | Buy |
Mostra tutto
Precision Biosciences Inc Borsa (DTIL) Ultime notizie
Is Precision BioSciences Inc. reversing from oversold territoryEarnings Summary Report & Consistent Income Trade Recommendations - newser.com
Can Precision BioSciences Inc. stock resist market sell offs - newser.com
Precision BioSciences Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Key metrics from Precision BioSciences Inc.’s quarterly dataTrade Volume Summary & Free Technical Pattern Based Buy Signals - newser.com
Is Precision BioSciences Inc. meeting your algorithmic filter criteriaQuarterly Growth Report & Community Driven Trade Alerts - newser.com
What high frequency data says about Precision BioSciences Inc.July 2025 Opening Moves & High Conviction Buy Zone Alerts - newser.com
Will Precision BioSciences Inc. stock gain from lower inflationPortfolio Value Report & Fast Moving Stock Trade Plans - newser.com
News impact scoring models applied to Precision BioSciences Inc.IPO Watch & Free Technical Pattern Based Buy Signals - newser.com
Using RSI to spot recovery in Precision BioSciences Inc.Market Movement Recap & AI Forecasted Entry and Exit Points - newser.com
Will Precision BioSciences Inc. stock recover faster than marketTrade Ideas & Weekly Hot Stock Watchlists - newser.com
What moving averages say about Precision BioSciences Inc.July 2025 Fed Impact & Expert Approved Momentum Trade Ideas - newser.com
Precision BioSciences Announces Publication in Nucleic Acids Research Elucidating the Mechanisms for - PharmiWeb.com
Precision BioSciences (DTIL) Showcases Genomic Advances with ARCUS Technology - GuruFocus
Precision BioSciences publishes research on ARCUS gene editing platform By Investing.com - Investing.com Canada
Relative strength of Precision BioSciences Inc. in sector analysisWall Street Watch & Community Verified Swing Trade Signals - newser.com
Precision BioSciences Announces Publication in Nucleic Acids Research Elucidating the Mechanisms for High Efficiency Gene Insertion in Dividing and Non-Dividing Cells Using ARCUS Nucleases - The AI Journal
Best data tools to analyze Precision BioSciences Inc. stockMarket Risk Analysis & Weekly High Potential Alerts - newser.com
Regression analysis insights on Precision BioSciences Inc. performanceJuly 2025 Macro Moves & High Return Trade Opportunity Guides - newser.com
Does Precision BioSciences Inc. qualify in momentum factor screeningWeekly Trade Review & Risk Managed Investment Entry Signals - newser.com
Is Precision BioSciences Inc. (PBS0) stock a top dividend aristocrat candidateJuly 2025 Movers & Safe Entry Point Identification - newser.com
Why retail investors pile into Precision BioSciences Inc. stock2025 Market Overview & Reliable Volume Spike Alerts - newser.com
Precision BioSciences (NASDAQ:DTIL) Earns "Sell (E+)" Rating from Weiss Ratings - MarketBeat
Precision BioSciences Announces Opening of First Clinical Trial Site in U.S. for ELIMINATE-B Trial - BioSpace
Precision Biosciences, Inc. Announces Opening of First Clinical Trial Site in U.S. for Eliminate-B Trial - MarketScreener
Precision BioSciences (DTIL) Commences U.S. Clinical Trial for P - GuruFocus
Automated trading signals detected on Precision BioSciences Inc.July 2025 Trends & Safe Entry Zone Tips - newser.com
Can Precision BioSciences Inc. (PBS0) stock hold up in economic slowdownPortfolio Risk Report & Reliable Price Action Trade Plans - newser.com
What momentum indicators show for Precision BioSciences Inc. stockOptions Play & Verified Swing Trading Watchlist - newser.com
Order flow analysis tools used on Precision BioSciences Inc.Weekly Gains Report & Fast Exit Strategy with Risk Control - newser.com
Can a trend reversal in Precision BioSciences Inc. lead to recoveryWeekly Investment Summary & Fast Exit and Entry Strategy Plans - newser.com
Why Precision BioSciences Inc. stock is rated strong buyTrade Risk Assessment & Precise Entry and Exit Recommendations - newser.com
Published on: 2025-10-05 04:45:59 - newser.com
Why Precision BioSciences Inc. stock attracts high net worth investorsTrade Risk Summary & Free High Return Stock Watch Alerts - newser.com
Why global investors buy Precision BioSciences Inc. (PBS0) stock2025 Fundamental Recap & Safe Investment Capital Preservation Plans - newser.com
Published on: 2025-10-03 06:51:55 - newser.com
How to integrate Precision BioSciences Inc. into portfolio analysis toolsQuarterly Risk Review & Daily Price Action Insights - newser.com
Is Precision BioSciences Inc. (PBS0) stock undervalued by metricsJuly 2025 Trends & High Conviction Trade Alerts - newser.com
Is Precision BioSciences Inc. building a consolidation baseMarket Growth Summary & High Accuracy Trade Signal Alerts - newser.com
Precision Biosciences Inc Azioni (DTIL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Precision Biosciences Inc Azioni (DTIL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Brown Melinda | Director |
Sep 22 '25 |
Buy |
4.89 |
1,400 |
6,846 |
21,965 |
| Kelly John Alexander | Chief Financial Officer |
Jul 03 '25 |
Sale |
4.26 |
14,827 |
63,163 |
73,485 |
5.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):